TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/14/2025
Back to search
Official data from USPTO
ALLAY THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ALLAY THERAPEUTICS
ST13
US500000090394146Class
5, 10
Filing
90394146
Registration
6925691
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
07/15/2025
Trademark type
Word
Nice classes
5, 10
Filing date
12/18/2020
Registration date
12/13/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/13/2022
Last transaction
07/15/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
05/03/2022
First use in commerce
05/03/2022
Drawing code
4
Owner type
03
Owner location
MENLO PARK, CA
Examiner
DUONG,ANGELA GAW
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
ALLAY THERAPEUTICS, INC.
Foundry Therapeutics 1, Inc.
Representatives
Elizabeth Breakstone Hillis Clark Martin & Peterson P.S.
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Analgesics; preparation for the relief of painimplantable pharmaceutical composition for treatment of pain; Anesthetics for surgical and non-surgical use; anesthetics for peri-operative and post- operative use; pharmaceutical preparations and substances for use in anesthesia and for the treatment and control of pain; Pharmaceutical preparationspolymer formulations containing preparations and substances for use in anesthesia and for the treatment and control of pain; Pharmaceutical preparationssustained release anesthetic formulations for the treatment of acute and subacute postoperative pain
Class 10
Medical apparatus for treating degenerative bone diseases and joint diseases surgically implanted by medical professional; Medical apparatus for use in immediate and sustained release of therapeutic agents in joint surgery surgically implanted by medical professional; Medical apparatus for use in pain treatment and control in joint surgery surgically implanted by medical professional; Medical apparatus for use in immediate and sustained release of therapeutic agents in knee repairrevision and replacement surgically implanted by medical professional; Medical apparatus for use in pain treatment and control in knee repairrevision and replacement surgically implanted by medical professional
Publications
History of USPTO decisions and trademark events.
37 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/14/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/14/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/13/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
12/13/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
11/10/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11/09/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/02/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/02/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/02/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/18/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/17/2022
IUAF
USE AMENDMENT FILED
10/03/2022
EISU
TEAS STATEMENT OF USE RECEIVED
10/03/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/29/2022
EX1G
SOU EXTENSION 1 GRANTED
09/27/2022
EXT1
SOU EXTENSION 1 FILED
09/27/2022
EEXT
SOU TEAS EXTENSION RECEIVED
09/27/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/29/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/01/2022
PUBO
PUBLISHED FOR OPPOSITION
02/01/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/12/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/29/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
12/29/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/29/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
12/29/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/29/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/24/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/23/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/23/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/23/2021
GNRT
NON-FINAL ACTION E-MAILED
06/23/2021
CNRT
NON-FINAL ACTION WRITTEN
06/23/2021
DOCK
ASSIGNED TO EXAMINER
06/12/2021
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
05/12/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/02/2021
NWAP
NEW APPLICATION ENTERED
12/22/2020
Continuous trademark protection
Get notified about every new filing that threatens ALLAY THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.